Follow
Merav Mofaz
Merav Mofaz
Ph.D., Department of Industrial Engineering, Tel Aviv University
Verified email at mail.tau.ac.il
Title
Cited by
Cited by
Year
Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine
Y Gepner, M Mofaz, S Oved, M Yechezkel, K Constantini, N Goldstein, ...
Communications Medicine 2 (1), 27, 2022
252022
Self-reported and physiologic reactions to third BNT162b2 mRNA COVID-19 (booster) vaccine dose
M Mofaz, M Yechezkel, G Guan, ML Brandeau, T Patalon, S Gazit, ...
Emerging Infectious Diseases 28 (7), 1375, 2022
232022
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
M Yechezkel, M Mofaz, A Painsky, T Patalon, S Gazit, E Shmueli, D Yamin
The Lancet Respiratory Medicine 11 (2), 139-150, 2023
222023
Differential effects of COVID-19 lockdowns on well-being: interaction between age, gender and chronotype
S Oved, M Mofaz, A Lan, H Einat, N Kronfeld-Schor, D Yamin, E Shmueli
Journal of the Royal Society Interface 18 (179), 20210078, 2021
222021
Higher sensitivity monitoring of reactions to COVID-19 vaccination using smartwatches
G Guan, M Mofaz, G Qian, T Patalon, E Shmueli, D Yamin, ML Brandeau
NPJ Digital Medicine 5 (1), 140, 2022
112022
Real-time sensing of war’s effects on wellbeing with smartphones and smartwatches
M Mofaz, M Yechezkel, H Einat, N Kronfeld-Schor, D Yamin, E Shmueli
Communications Medicine 3 (1), 55, 2023
52023
P. 0518 Effects of COVID-19 lockdowns on well-being in subgroups of the population
A Lan, T Ron, S Oved, M Mofaz, N Kronfeld-Schor, D Yamin, Y Stukalin, ...
European Neuropsychopharmacology 53, S382, 2021
12021
Risk and early signs of PTSD in people indirectly exposed to October 7 events
D Yamin, S Lev-Ari, M Mofaz, R Elias, D Spiegel, M Yechezkel, ...
medRxiv, 2023.12. 15.23300048, 2023
2023
The World Cup Is in Our Hearts
M Mofaz, D Yamin, E Shmueli
Available at SSRN 4336479, 2023
2023
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine
M Yechezkel, M Mofaz, T Patalon, S Gazit, E Shmueli, D Yamin
medRxiv, 2022.06. 07.22276117, 2022
2022
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine (preprint)
M Yechezkel, M Mofaz, T Patalon, S Gazit, E Shmueli, D Yamin
2022
Short-term effects of BNT162b2 mRNA COVID-19 vaccination on physiological measures: a prospective study
Y Gepner, M Mofaz, S Oved, M Yechezkel, K Constantini, N Goldstein, ...
medRxiv, 2021.05. 06.21256587, 2021
2021
Short-term effects of BNT162b2 mRNA COVID-19 vaccination on physiological measures: a prospective study (preprint)
Y Gepner, M Mofaz, S Oved, M Yechezkel, K Constantini, N Goldstein, ...
2021
Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose (preprint)
M Mofaz, M Yechezkel, G Guan, ML Brandeau, T Patalon, S Gazit, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–14